摘要
目的:评估沙利度胺治疗慢性病贫血的临床疗效,观察其不良反应。方法:对2011年3月至2011年10月我院26例慢性病贫血患者的临床资料进行分析,采用沙利度胺治疗,必要时输注红细胞纠正贫血。结果:26例患者中有效15例,有效率57.7%,无效11例,无效率42.3%,其中死亡2例。结论:沙利度胺治疗慢性病贫血有较好疗效,不良反应小,值得进一步推广。
Objective :To estimate the clinical effect of thalidomide in treating anemia of chronic disease (ACD) and observe its adverse reactions. Methods:26 patients diagnosed as ACD from March, 2011 to October, 2011 were treated with thalidomide and injected with red blood cell (RBC) for treating anemia necessarily. Results: 15 patients had achieved good remission, the remission rate was 57.7%, while 11 patients had achieved no effect, the un-effective rate was 42.3%, 2 patients died. Conclusion:Thalidomide is an effective and safe drug in treating ACD with side effects being mild, so it is worth further spreading.
出处
《赣南医学院学报》
2012年第2期231-232,共2页
JOURNAL OF GANNAN MEDICAL UNIVERSITY
基金
2011年赣州市指导性科技计划项目(编号:178)
关键词
沙利度胺
慢性病贫血
ACD
Thalidomide
Anemia of chronic disease
ACD